Skip to content

A Study to Check Whether the Test Product Causes Skin Allergy or Irritation When Applied Repeatedly to the Skin

Evaluation of skin sensitization potential of investigational products by Human Repeat Insult Patch Test (HRIPT) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111779
Enrollment
50
Registered
2026-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Baby massage oil (DRDC/2026/007): 40 ul of the product will be applied to the participants back with no dilution on Visits 2, 3, 4, 5, 6, 7, 8, 9, 10, 13 and 17. Control Intervention1:

Sponsors

Dabur Research Development Centre Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy male & female participants in the age group 18 - 65 years (both ages inclusive). 2. Trial participants must be generally in good health as determined from a recent medical history which is on file with the investigator. 3. The ability of the trial participant to understand and sign a written informed consent form which must be obtained prior to treatment. 4. Willingness to avoid UV exposure (sun or artificial UV) on the test sites during the course of the study. 5. Trial participants must have clear back. They should not have any infection or allergy in the tested area. They should have healthy skin in the test area 6. Trial participants should be cooperative, informed of the need and duration of the examination and ready to comply with the protocol procedures 7. Trial participants having valid proof of identity and age. 8. Willingness to avoid excessive water contact (like swimming etc.) or activity which causes excessive sweating (like exercise, sauna, etc.) during the course of study

Exclusion criteria

Exclusion criteria: 1. Pregnant women/ Nursing mothers (self-declared) 2. Scars or excessive terminal hair on the study area. 3. Tattoo on the study area. 4. Henna tattoo anywhere on the body (in case of studies involving hair dyes). 5. Dermatological infection/pathology on the level of the study area 6. Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 7. Any clinically significant systematic or cutaneous disease, which may interfere with study treatment or procedures 8. Chronic illness which may influence the outcome of the study. 9. Trial participant on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 10. Trial participant in an exclusion period or participating in another food, cosmetic or therapeutic trial. 11. Trial participants having mole or hair on the back which may influence the study results as per the investigator

Design outcomes

Primary

MeasureTime frame
To determine the sensitization potential of the product To determine the cumulative irritation potential of the test product by 9 occlusive applications.Timepoint: Visit 12, Visit 16, Visit 20

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactSudhanthiran S

MS Clinical Research Pvt. Ltd

ritambhara@msclinical.com08040917253

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026